Toray Medical Co Ltd - Product Pipeline Analysis, 2022 Update

Summary

Toray Medical Co Ltd (Toray Medical), a subsidiary of Toray Industries Inc is a medical device company that offers a range of medical equipments and pharmaceutical products. The company’s products comprise hemodialyzers, dialysis machines, balloon catheter for PTMC, blood purification devices for intensive care, indwelling vascular catheter for HAIC and x-ray protective eyewear. It offers products in therapeutic areas of cardiology, urology and nephrology, immunology and oncology. Toray Medical offers a series of hemodialyzers such as filtryzer and toraysulfone. The company has manufacturing facilities in Shizuoka, Okazaki, Seta, Shiga and Mishima. Toray Medical is headquartered in Tokyo, Japan.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Toray Medical Co Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Toray Medical Co Ltd Company Overview
Toray Medical Co Ltd Company Snapshot
Toray Medical Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
Toray Medical Co Ltd – Pipeline Analysis Overview
Toray Medical Co Ltd - Key Facts
Toray Medical Co Ltd - Major Products and Services
Toray Medical Co Ltd Pipeline Products by Development Stage
Toray Medical Co Ltd Ongoing Clinical Trials by Trial Status
Toray Medical Co Ltd Pipeline Products Overview
3D-Gene DNA Chip - Biliary Tract Cancer
3D-Gene DNA Chip - Biliary Tract Cancer Product Overview
3D-Gene DNA Chip - Breast Cancer
3D-Gene DNA Chip - Breast Cancer Product Overview
3D-Gene DNA Chip - Colon Cancer
3D-Gene DNA Chip - Colon Cancer Product Overview
3D-Gene DNA Chip - Dementia
3D-Gene DNA Chip - Dementia Product Overview
3D-Gene DNA Chip - Liver Cancer
3D-Gene DNA Chip - Liver Cancer Product Overview
3D-Gene DNA Chip - Lung Cancer
3D-Gene DNA Chip - Lung Cancer Product Overview
3D-Gene DNA Chip - Ovarian Cancer
3D-Gene DNA Chip - Ovarian Cancer Product Overview
3D-Gene DNA Chip - Pancreatic Cancer
3D-Gene DNA Chip - Pancreatic Cancer Product Overview
3D-Gene DNA Chip - Prostate Cancer
3D-Gene DNA Chip - Prostate Cancer Product Overview
3D-Gene DNA Chip - Stomach Cancer
3D-Gene DNA Chip - Stomach Cancer Product Overview
Adhesion Barrier
Adhesion Barrier Product Overview
Allergy Testing Biochip
Allergy Testing Biochip Product Overview
Artificial Kidney
Artificial Kidney Product Overview
Dialysis Complication Treatment Column
Dialysis Complication Treatment Column Product Overview
Epurina
Epurina Product Overview
Filtor
Filtor Product Overview
PMMA Nanopore Fiber
PMMA Nanopore Fiber Product Overview
Respiratory Disease Treatment Column
Respiratory Disease Treatment Column Product Overview
Satake HotBalloon Catheter
Satake HotBalloon Catheter Product Overview
Toray Drug Delivery System
Toray Drug Delivery System Product Overview
Toray Leukocyte Removal Column
Toray Leukocyte Removal Column Product Overview
TORAYMYXIN PMX-20R
TORAYMYXIN PMX-20R Product Overview
TORAYMYXIN PMX-20R Clinical Trial
Toraymyxin - Idiopathic Pulmonary Fibrosis
Toraymyxin - Idiopathic Pulmonary Fibrosis Product Overview
Toray Medical Co Ltd - Key Competitors
Toray Medical Co Ltd - Key Employees
Toray Medical Co Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Toray Medical Co Ltd, Recent Developments
Feb 19, 2019: Toray Medical: Arab Health Exhibition 2019
Feb 24, 2016: Toray, Nanotheta, Taiho to Accelerate Business of Antiadhesive Material Based on Nano-scale Polymer Thin Film Technology
Sep 23, 2015: Advanced Catheter Therapies Receives Second FDA 510(k) Clearance on Occlusion Perfusion Catheter
Oct 08, 2013: Advanced Catheter Therapies Receives FDA 510(k) Clearance on Occlusion Perfusion Catheter
Jul 29, 2013: Advanced Catheter Therapies Awarded Patent
Sep 14, 2012: Advanced Catheter Receives Second Patent For Occlusion Perfusion Catheter
Jan 10, 2012: Advanced Catheter Therapies Announces Issuance Of US Patent
Oct 03, 2011: Toray And NCC Jointly Develop Innovative Blood Biomarker Identification Method
Mar 24, 2010: ACT Completes Prototype Phase In Development Of Occlusion Perfusion Catheter
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Toray Medical Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Toray Medical Co Ltd Pipeline Products by Equipment Type
Table 3: Toray Medical Co Ltd Pipeline Products by Indication
Table 4: Toray Medical Co Ltd, Key Facts
Table 5: Toray Medical Co Ltd, Major Products and Services
Table 6: Toray Medical Co Ltd Number of Pipeline Products by Development Stage
Table 7: Toray Medical Co Ltd Pipeline Products Summary by Development Stage
Table 8: Toray Medical Co Ltd Ongoing Clinical Trials by Trial Status
Table 9: Toray Medical Co Ltd Ongoing Clinical Trials Summary
Table 10: D-Gene DNA Chip - Biliary Tract Cancer - Product Status
Table 11: D-Gene DNA Chip - Biliary Tract Cancer - Product Description
Table 12: D-Gene DNA Chip - Breast Cancer - Product Status
Table 13: D-Gene DNA Chip - Breast Cancer - Product Description
Table 14: D-Gene DNA Chip - Colon Cancer - Product Status
Table 15: D-Gene DNA Chip - Colon Cancer - Product Description
Table 16: D-Gene DNA Chip - Dementia - Product Status
Table 17: D-Gene DNA Chip - Dementia - Product Description
Table 18: D-Gene DNA Chip - Liver Cancer - Product Status
Table 19: D-Gene DNA Chip - Liver Cancer - Product Description
Table 20: D-Gene DNA Chip - Lung Cancer - Product Status
Table 21: D-Gene DNA Chip - Lung Cancer - Product Description
Table 22: D-Gene DNA Chip - Ovarian Cancer - Product Status
Table 23: D-Gene DNA Chip - Ovarian Cancer - Product Description
Table 24: D-Gene DNA Chip - Pancreatic Cancer - Product Status
Table 25: D-Gene DNA Chip - Pancreatic Cancer - Product Description
Table 26: D-Gene DNA Chip - Prostate Cancer - Product Status
Table 27: D-Gene DNA Chip - Prostate Cancer - Product Description
Table 28: D-Gene DNA Chip - Stomach Cancer - Product Status
Table 29: D-Gene DNA Chip - Stomach Cancer - Product Description
Table 30: Adhesion Barrier - Product Status
Table 31: Adhesion Barrier - Product Description
Table 32: Allergy Testing Biochip - Product Status
Table 33: Allergy Testing Biochip - Product Description
Table 34: Artificial Kidney - Product Status
Table 35: Artificial Kidney - Product Description
Table 36: Dialysis Complication Treatment Column - Product Status
Table 37: Dialysis Complication Treatment Column - Product Description
Table 38: Epurina - Product Status
Table 39: Epurina - Product Description
Table 40: Filtor - Product Status
Table 41: Filtor - Product Description
Table 42: PMMA Nanopore Fiber - Product Status
Table 43: PMMA Nanopore Fiber - Product Description
Table 44: Respiratory Disease Treatment Column - Product Status
Table 45: Respiratory Disease Treatment Column - Product Description
Table 46: Satake HotBalloon Catheter - Product Status
Table 47: Satake HotBalloon Catheter - Product Description
Table 48: Toray Drug Delivery System - Product Status
Table 49: Toray Drug Delivery System - Product Description
Table 50: Toray Leukocyte Removal Column - Product Status
Table 51: Toray Leukocyte Removal Column - Product Description
Table 52: TORAYMYXIN PMX-20R - Product Status
Table 53: TORAYMYXIN PMX-20R - Product Description
Table 54: TORAYMYXIN PMX-20R - A Prospective, Multicenter, Randomized, Open-label Study to Evaluate the Efficacy and Safety of PMX Cartridge in Addition to Standard Medical Care for Patients with Endotoxemic Septic Shock
Table 55: TORAYMYXIN PMX-20R - Evaluation of the Efficacy and Safety of Hemoperfusion Use with Polymyxin B in Patients with Severe Endotoxemia With Multiple Organ Dysfunction Syndrome After Complicated Operations with Cardiopulmonary Bypass
Table 56: TORAYMYXIN PMX-20R - Exploratory Study on the Efficacy and Safety of Direct Hemoperfusion Using Polymyxin B-immobilized Polystyrene Column (PMX-DHP) for COVID-19 Patients (X-CODE)
Table 57: Toraymyxin - Idiopathic Pulmonary Fibrosis - Product Status
Table 58: Toraymyxin - Idiopathic Pulmonary Fibrosis - Product Description
Table 59: Toray Medical Co Ltd, Key Employees
Table 60: Glossary
List of Figures
Figure 1: Toray Medical Co Ltd Pipeline Products by Equipment Type
Figure 2: Toray Medical Co Ltd Pipeline Products by Development Stage
Figure 3: Toray Medical Co Ltd Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings